Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00667745 · ClinicalTrials.gov registry record · Phase 4
Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder
A Phase 4 study, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- Phase 4
- Development phase
- 283
- Enrollment target
NCT00667745 is a Phase 4 study that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 283 participants.
The verdict
NCT00667745, a Phase 4 study, has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 283 participants
- Enrollment target
Study Summary
This study evaluated whether lithium included as part of optimized medication treatment improved overall level of illness, symptoms of mania and depression, and quality of life in people with bipolar disorder.
Interventions
- DRUG Lithium Carbonate
- DRUG Optimized Treatment (OPT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 283 participants |
| Start Date | 2008-04 |
| Est. Completion | 2010-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00667745
The ClinicalTrials.gov registry entry for NCT00667745 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 283 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lithium Carbonate is the first listed.
NCT00667745 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00667745 about?
NCT00667745 is a clinical study titled "Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder". This study evaluated whether lithium included as part of optimized medication treatment improved overall level of illness, symptoms of mania and depression, and quality of life in people with bipolar disorder.
What is the current status of trial NCT00667745?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 283 participants. The study started on 2008-04. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00667745?
The interventions under investigation include: Lithium Carbonate (DRUG), Optimized Treatment (OPT) (DRUG).
Who is sponsoring clinical trial NCT00667745?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.